Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028181921> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2028181921 endingPage "1171" @default.
- W2028181921 startingPage "1168" @default.
- W2028181921 abstract "To determine whether the antiplatelet drug dilazep dihydrochloride affects the number of urinary podocytes in diabetic patients with microalbuminuria.Fifty patients with type 2 diabetes and microalbuminuria (30 men and 20 women, mean age 48.6 years) and 30 age-matched control subjects (18 men and 12 women, mean age 49.2 years) were included in the study. No patients showed serum creatinine levels in excess of 2.0 mg/dl. Urinary podocytes were examined by immunofluorescence microscopy with monoclonal antibodies against podocalyxin.Urinary podocytes were detected in 18 of the 50 microalbuminuric diabetic patients (mean, 1.3 cells/ml). Urinary podocytes were not detected in the remaining 32 patients or in the 30 healthy control subjects. Diabetic patients positive for urinary podocytes were divided into 2 treatment groups: a dilazep dihydrochloride treatment group (300 mg/day; n = 9, group A) and a placebo group (n = 9, group B). Treatments were continued for 6 months. In group A, microalbuminuria decreased significantly from 146 +/- 42 to 86 +/- 28 microg/min (P < 0.01) and urinary podocytes also decreased from 1.3 +/- 0.8 to 0.4 +/- 0.2 cells/ml (P < 0.01). However, in group B, microalbuminuria and urinary podocytes changed little over the study period.Podocyte injury may occur in patients with early diabetic nephropathy, and dilazep dihydrochloride may be useful for preventing glomerular injury." @default.
- W2028181921 created "2016-06-24" @default.
- W2028181921 creator A5021468317 @default.
- W2028181921 creator A5030431269 @default.
- W2028181921 creator A5032660436 @default.
- W2028181921 creator A5037863670 @default.
- W2028181921 creator A5038547315 @default.
- W2028181921 creator A5062409747 @default.
- W2028181921 creator A5083088614 @default.
- W2028181921 date "2000-08-01" @default.
- W2028181921 modified "2023-10-16" @default.
- W2028181921 title "Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy." @default.
- W2028181921 doi "https://doi.org/10.2337/diacare.23.8.1168" @default.
- W2028181921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10937516" @default.
- W2028181921 hasPublicationYear "2000" @default.
- W2028181921 type Work @default.
- W2028181921 sameAs 2028181921 @default.
- W2028181921 citedByCount "37" @default.
- W2028181921 countsByYear W20281819212012 @default.
- W2028181921 countsByYear W20281819212013 @default.
- W2028181921 countsByYear W20281819212014 @default.
- W2028181921 countsByYear W20281819212015 @default.
- W2028181921 countsByYear W20281819212016 @default.
- W2028181921 countsByYear W20281819212022 @default.
- W2028181921 countsByYear W20281819212023 @default.
- W2028181921 crossrefType "journal-article" @default.
- W2028181921 hasAuthorship W2028181921A5021468317 @default.
- W2028181921 hasAuthorship W2028181921A5030431269 @default.
- W2028181921 hasAuthorship W2028181921A5032660436 @default.
- W2028181921 hasAuthorship W2028181921A5037863670 @default.
- W2028181921 hasAuthorship W2028181921A5038547315 @default.
- W2028181921 hasAuthorship W2028181921A5062409747 @default.
- W2028181921 hasAuthorship W2028181921A5083088614 @default.
- W2028181921 hasBestOaLocation W20281819211 @default.
- W2028181921 hasConcept C126322002 @default.
- W2028181921 hasConcept C126894567 @default.
- W2028181921 hasConcept C134018914 @default.
- W2028181921 hasConcept C2777146197 @default.
- W2028181921 hasConcept C2779561371 @default.
- W2028181921 hasConcept C2779922275 @default.
- W2028181921 hasConcept C2780091579 @default.
- W2028181921 hasConcept C2780306776 @default.
- W2028181921 hasConcept C2781156571 @default.
- W2028181921 hasConcept C2781184683 @default.
- W2028181921 hasConcept C2781203188 @default.
- W2028181921 hasConcept C555293320 @default.
- W2028181921 hasConcept C71924100 @default.
- W2028181921 hasConcept C77411442 @default.
- W2028181921 hasConcept C90924648 @default.
- W2028181921 hasConceptScore W2028181921C126322002 @default.
- W2028181921 hasConceptScore W2028181921C126894567 @default.
- W2028181921 hasConceptScore W2028181921C134018914 @default.
- W2028181921 hasConceptScore W2028181921C2777146197 @default.
- W2028181921 hasConceptScore W2028181921C2779561371 @default.
- W2028181921 hasConceptScore W2028181921C2779922275 @default.
- W2028181921 hasConceptScore W2028181921C2780091579 @default.
- W2028181921 hasConceptScore W2028181921C2780306776 @default.
- W2028181921 hasConceptScore W2028181921C2781156571 @default.
- W2028181921 hasConceptScore W2028181921C2781184683 @default.
- W2028181921 hasConceptScore W2028181921C2781203188 @default.
- W2028181921 hasConceptScore W2028181921C555293320 @default.
- W2028181921 hasConceptScore W2028181921C71924100 @default.
- W2028181921 hasConceptScore W2028181921C77411442 @default.
- W2028181921 hasConceptScore W2028181921C90924648 @default.
- W2028181921 hasIssue "8" @default.
- W2028181921 hasLocation W20281819211 @default.
- W2028181921 hasLocation W20281819212 @default.
- W2028181921 hasOpenAccess W2028181921 @default.
- W2028181921 hasPrimaryLocation W20281819211 @default.
- W2028181921 hasRelatedWork W1555783812 @default.
- W2028181921 hasRelatedWork W2028181921 @default.
- W2028181921 hasRelatedWork W2352029722 @default.
- W2028181921 hasRelatedWork W2365994945 @default.
- W2028181921 hasRelatedWork W2380303926 @default.
- W2028181921 hasRelatedWork W2384292668 @default.
- W2028181921 hasRelatedWork W2391103614 @default.
- W2028181921 hasRelatedWork W2912337063 @default.
- W2028181921 hasRelatedWork W4309314715 @default.
- W2028181921 hasRelatedWork W2416054993 @default.
- W2028181921 hasVolume "23" @default.
- W2028181921 isParatext "false" @default.
- W2028181921 isRetracted "false" @default.
- W2028181921 magId "2028181921" @default.
- W2028181921 workType "article" @default.